1. Home
  2. GCTK vs STEC Comparison

GCTK vs STEC Comparison

Compare GCTK & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • STEC
  • Stock Information
  • Founded
  • GCTK 2001
  • STEC 2006
  • Country
  • GCTK United States
  • STEC China
  • Employees
  • GCTK N/A
  • STEC N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • STEC
  • Sector
  • GCTK Health Care
  • STEC
  • Exchange
  • GCTK Nasdaq
  • STEC NYSE
  • Market Cap
  • GCTK 7.1M
  • STEC 6.3M
  • IPO Year
  • GCTK N/A
  • STEC 2021
  • Fundamental
  • Price
  • GCTK $2.17
  • STEC $1.59
  • Analyst Decision
  • GCTK
  • STEC
  • Analyst Count
  • GCTK 0
  • STEC 0
  • Target Price
  • GCTK N/A
  • STEC N/A
  • AVG Volume (30 Days)
  • GCTK 10.0K
  • STEC 4.5M
  • Earning Date
  • GCTK 11-02-2024
  • STEC 10-29-2024
  • Dividend Yield
  • GCTK N/A
  • STEC N/A
  • EPS Growth
  • GCTK N/A
  • STEC N/A
  • EPS
  • GCTK N/A
  • STEC N/A
  • Revenue
  • GCTK N/A
  • STEC $260,474,693.00
  • Revenue This Year
  • GCTK N/A
  • STEC $9.76
  • Revenue Next Year
  • GCTK N/A
  • STEC $15.85
  • P/E Ratio
  • GCTK N/A
  • STEC N/A
  • Revenue Growth
  • GCTK N/A
  • STEC N/A
  • 52 Week Low
  • GCTK $0.67
  • STEC $0.20
  • 52 Week High
  • GCTK $4.95
  • STEC $7.38
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 41.99
  • STEC 64.50
  • Support Level
  • GCTK $2.11
  • STEC $0.32
  • Resistance Level
  • GCTK $2.29
  • STEC $3.25
  • Average True Range (ATR)
  • GCTK 0.10
  • STEC 0.21
  • MACD
  • GCTK -0.02
  • STEC 0.16
  • Stochastic Oscillator
  • GCTK 50.49
  • STEC 43.38

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.

Share on Social Networks: